Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monogenic lupus: insights into disease pathogenesis and therapeutic opportunities. | Curr Opin Rheumatol | 2024 | 38420886 | PubTator, text mining | PubMed |
| Triple-fusion protein (TriFu): A potent, targeted, enzyme-like inhibitor of all three complement activation pathways. | J Biol Chem | 2024 | 38401844 | PubTator, text mining | PubMed |
| Complex changes in serum protein levels in COVID-19 convalescents. | Sci Rep | 2024 | 38396092 | PubTator, text mining | PubMed |
| Molecular Interactions Required for Activation of Complement Component C2 Include Exosites Located on the Serine Protease Domain of C1s and Mannose-Binding Lectin Associated Protease-2. | J Immunol | 2024 | 38372634 | PubTator, text mining | PubMed |
| Complement dysregulation is a prevalent and therapeutically amenable feature of long COVID. | Med | 2024 | 38359836 | PubTator, text mining | PubMed |
| The Inhibition of Serine Proteases by Serpins Is Augmented by Negatively Charged Heparin: A Concise Review of Some Clinically Relevant Interactions. | Int J Mol Sci | 2024 | 38339082 | PubTator, text mining | PubMed |
| Revealing neuropilin expression patterns in pancreatic cancer: From single‑cell to therapeutic opportunities (Review). | Oncol Lett | 2024 | 38304169 | PubTator, text mining | PubMed |
| Recombinant therapeutic proteins degradation and overcoming strategies in CHO cells. | Appl Microbiol Biotechnol | 2024 | 38285115 | PubTator, text mining | PubMed |
| Investigation of Potential Drug Targets Involved in Inflammation Contributing to Alzheimer's Disease Progression. | Pharmaceuticals (Basel) | 2024 | 38276010 | PubTator, text mining | PubMed |
| Exosome-mediated regulation of inflammatory pathway during respiratory viral disease. | Virol J | 2024 | 38273382 | PubTator, text mining | PubMed |
| An update on recent studies of extracellular vesicles and their role in hypercoagulability in thalassemia (Review). | Biomed Rep | 2024 | 38259586 | PubTator, text mining | PubMed |
| Storage of Transfusion Platelet Concentrates Is Associated with Complement Activation and Reduced Ability of Platelets to Respond to Protease-Activated Receptor-1 and Thromboxane A2 Receptor. | Int J Mol Sci | 2024 | 38256162 | PubTator, text mining | PubMed |
| Cerebrospinal Fluid C1-Esterase Inhibitor and Tie-1 Levels Affect Cognitive Performance: Evidence from Proteome-Wide Mendelian Randomization. | Genes (Basel) | 2024 | 38254961 | PubTator, text mining | PubMed |
| scQA: A dual-perspective cell type identification model for single cell transcriptome data. | Comput Struct Biotechnol J | 2024 | 38235363 | PubTator, text mining | PubMed |
| C1QBP is a critical component in the immune response of large yellow croaker (Larimichthys crocea) against visceral white spot disease caused by Pseudomonas plecoglossicida. | Fish Shellfish Immunol | 2024 | 38218420 | PubTator, text mining | PubMed |
| Cytoprotective effects of C1s enzyme in macrophages in atherosclerosis mediated through the LRP5 and Wnt/β-catenin pathway. | Mol Immunol | 2024 | 38218080 | PubTator, text mining | PubMed |
| Unsupervised spatially embedded deep representation of spatial transcriptomics. | Genome Med | 2024 | 38217035 | PubTator, text mining | PubMed |
| The intricate cellular ecosystem of human peripheral veins as revealed by single-cell transcriptomic analysis. | PLoS One | 2024 | 38206912 | PubTator, text mining | PubMed |
| Speeding up iterative applications of the BUILD supertree algorithm. | PeerJ | 2024 | 38188165 | PubTator, text mining | PubMed |
| The complement cascade in lung injury and disease. | Respir Res | 2024 | 38178176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=9